Physician profile
Drew Hecht
NPI 1891736229
$1,496.87
in general payments reported to CMS, 2019-2025
23 companies · $96.62 in 2025
The $96.62 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,227 · 2020: $116 · 2021: $57.42 · 2025: $96.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $96.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $96.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $359.12 | 2019-2020 | |
| Medtronic USA, INC. | $248.41 | 2019-2020 | |
| Neotract INC. | $137.60 | 2019 | |
| Pfizer INC. | $134.94 | 2019-2025 | |
| Janssen Biotech, INC. | $122.26 | 2019-2020 | |
| Abbvie INC. | $91.32 | 2019-2021 | |
| Boston Scientific Corporation | $45.12 | 2019-2021 | |
| Amgen INC. | $44.77 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $43.28 | 2019 | |
| Endo Pharmaceuticals INC. | $38.92 | 2019 | |
| Aytu Biopharma, INC. | $27.04 | 2019 | |
| Dendreon Pharmaceuticals LLC | $23.57 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.12 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $21.05 | 2019 | |
| Antares Pharma, INC. | $20.59 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $19.20 | 2019 | |
| Blue Earth Diagnostics | $18.46 | 2019 | |
| Mission Pharmacal Company | $15.61 | 2019 | |
| Medtronic, INC. | $14.93 | 2021 | |
| Ferring Pharmaceuticals INC. | $12.92 | 2019 | |
| Cure Medical LLC | $12.92 | 2020 | |
| Metuchen Pharmaceuticals | $12.89 | 2019 | |
| Coloplast Corp | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Drew Hecht listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.